Owner Thallion Pharmaceuticals Inc.

Inventors Piraee, Mahmood; Farnet, Chris M.; McAlpine, James B.; Bachmann, Brian O.; Zazopoulos, Emmanuel

Agent Shelston IP

Pub. Number AU-B-2004206046

PCT Pub. Number WO2004/065591

Priority 60/518,286 10.11.03 US; 60/441,126 21.01.03 US; 60/492,997 07.08.03 US

Filing date 21 January 2004

Wipo publication date 5 August 2004

Acceptance publication date 17 December 2009

C07D 243/38 (2006.01) Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 9/14 (2006.01) Enzymes, e.g. ligases (6.) - Hydrolases (3.)

C12N 9/88 (2006.01) Enzymes, e.g. ligases (6.) - Lyases (4.)

C12N 9/90 (2006.01) Enzymes, e.g. ligases (6.) - Isomerases (5.)

C12N 15/52 (2006.01) Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

C12P 17/10 (2006.01) Preparation of heterocyclic carbon compounds with only O, N, S, Se, or Te as ring hetero atoms - Nitrogen as only ring hetero atom

A61K 38/00 (2006.01) Medicinal preparations containing peptides